India Block speaks to paediatrician and TV writer Dr Neal Baer about the controversial technology and how it could reshape ...

CRISPR Therapeutics ($CRSP) has endured a tough year since gaining several important regulatory approvals for its ...

The "Sickle Cell Disease - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.A recent epidemiological forecast provides vital insight into Molybdenum Cofactor ...

A team of UC Davis Health researchers has shown that CD34+ stem cells can be safely administered into retinitis pigmentosa ...

Sickle cell disease occurs when a child inherits two sickle cell genes—one from each parent. Lillian knew she carried the ...

UCSF Benioff Children's Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell ...

The matter of what causes complicated neurological disorders like Alzheimer's or multiple sclerosis continues to perplex scientists and doctors, with unknowns impeding early diagnosis and successful ...

The genome-editing technology can be supercharged by artificial intelligence—and the results are already being felt.

Chinese gene therapy firm Kanglin Biotechnology has completed a $20 million series A financing round, with the money ...

Editas Medicine faces a downgrade to Underperform from BofA, citing competition, limited catalysts, and a reduced price ...

Kanglin Biotech is a China based company, focusing on the research, development and commercialization of first-in-class and best-in-class gene therapy drugs, most of which are targeted at diseases ...

Muhammad Ibrahim, has cancelled his wedding ceremony after medical tests revealed he is not genetically compatible with his ...